新型 FKS 突变与棘白菌素类耐药的念珠菌属相关。
Novel FKS mutations associated with echinocandin resistance in Candida species.
机构信息
Public Health Research Institute, Newark, New Jersey, USA.
出版信息
Antimicrob Agents Chemother. 2010 May;54(5):2225-7. doi: 10.1128/AAC.00998-09. Epub 2010 Feb 9.
Abstract
We studied three clinical isolates of Candida spp. (one C. tropicalis isolate and two C. glabrata isolates) from patients with invasive candidiasis. The first isolate emerged during echinocandin treatment, while the others emerged after the same treatment. These strains harbored an amino acid substitution in Fksp never linked before with reduced echinocandin susceptibility in C. tropicalis or in C. glabrata. The molecular mechanism of reduced susceptibility was confirmed using a 1,3-beta-D-glucan synthase inhibition assay.
摘要
我们研究了三株来自侵袭性念珠菌病患者的念珠菌属（一株热带念珠菌和两株光滑念珠菌）的临床分离株。第一株分离株在棘白菌素治疗期间出现，而其他两株在相同治疗后出现。这些菌株携带了以前从未与棘白菌素敏感性降低相关的 Fksp 氨基酸取代，这种敏感性降低在热带念珠菌或光滑念珠菌中从未出现过。使用 1,3-β-D-葡聚糖合酶抑制试验证实了这种低敏感性的分子机制。
相似文献
1
Novel FKS mutations associated with echinocandin resistance in Candida species.新型 FKS 突变与棘白菌素类耐药的念珠菌属相关。
Antimicrob Agents Chemother. 2010 May;54(5):2225-7. doi: 10.1128/AAC.00998-09. Epub 2010 Feb 9.
2
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.棘白菌素类耐药性在光滑念珠菌中的增加：临床失败与 FKS 突变和最低抑菌浓度升高相关。
Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13.
3
FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.氟康唑敏感基因 2 （FKS2）突变与棘白菌素类药物治疗后光滑念珠菌对棘白菌素类药物敏感性降低相关。
Antimicrob Agents Chemother. 2011 Mar;55(3):1312-4. doi: 10.1128/AAC.00589-10. Epub 2010 Dec 13.
4
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响：对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
5
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.FKS 突变的光滑念珠菌：菌血症患者的危险因素和结局。
Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30.
6
Echinocandin Resistance in Candida.念珠菌中的棘白菌素耐药性
Clin Infect Dis. 2015 Dec 1;61 Suppl 6(Suppl 6):S612-7. doi: 10.1093/cid/civ791.
7
Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.口服葡聚糖合酶抑制剂SCY-078对白色念珠菌野生型和棘白菌素耐药菌株的差异活性
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00161-17. Print 2017 Aug.
8
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.棘白菌素类耐药性在念珠菌属中的研究进展：敏感性降低的机制与治疗方法。
Ann Pharmacother. 2012 Jul-Aug;46(7-8):1086-96. doi: 10.1345/aph.1R020. Epub 2012 Jul 17.
9
Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.FKS基因在致病真菌对棘白菌素敏感性中的作用
Med Mycol J. 2018;59(2):E31-E40. doi: 10.3314/mmj.18.004.
10
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
引用本文的文献
1
Antifungal drug resistance in Candida glabrata: role of cellular signaling and gene regulatory networks.光滑念珠菌的抗真菌药物耐药性：细胞信号传导和基因调控网络的作用
FEMS Yeast Res. 2025 Jan 30;25. doi: 10.1093/femsyr/foaf025.
2
Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates.光滑念珠菌棘白菌素耐药系列分离株中FKS1和FKS2之间的热点基因转换
NPJ Antimicrob Resist. 2025 Apr 17;3(1):31. doi: 10.1038/s44259-025-00102-6.
3
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.超越传统抗真菌药物：通过新型治疗途径对抗耐药性。
Pharmaceuticals (Basel). 2025 Mar 4;18(3):364. doi: 10.3390/ph18030364.
4
: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen.一种主要机会性真菌病原体中的多药耐药性与毒力增强
Curr Fungal Infect Rep. 2012 Jun;6(3):154-164. doi: 10.1007/s12281-012-0091-0.
5
A MALDI-TOF MS-based multiple detection panel of drug resistance-associated multiple single-nucleotide polymorphisms in .一种基于基质辅助激光解吸电离飞行时间质谱的耐药相关多个单核苷酸多态性多重检测面板，用于…… （原文结尾不完整）
Microbiol Spectr. 2025 Jan 7;13(1):e0076424. doi: 10.1128/spectrum.00764-24. Epub 2024 Dec 6.
6
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Species.与致病物种中抗真菌耐药性相关的分子机制。
Cells. 2023 Nov 19;12(22):2655. doi: 10.3390/cells12222655.
7
Aneuploidy enables cross-tolerance to unrelated antifungal drugs in .非整倍体使[具体生物]对不相关抗真菌药物产生交叉耐受性。 （你提供的原文“Aneuploidy enables cross-tolerance to unrelated antifungal drugs in.”似乎不完整，这里补充了推测的“[具体生物]”使句子完整表意，你可根据实际情况调整。）
Front Microbiol. 2023 Apr 11;14:1137083. doi: 10.3389/fmicb.2023.1137083. eCollection 2023.
8
species isolated from clinical samples in a tertiary hospital in Honduras: Where is ?从洪都拉斯一家三级医院的临床样本中分离出的物种：在哪里？ （原句表述不太完整和准确，翻译出来的内容可能也稍显奇怪，推测原句可能是“species isolated from clinical samples in a tertiary hospital in Honduras: Where is it?” ，完整意思是“从洪都拉斯一家三级医院的临床样本中分离出的物种：它在哪里？” ）
Curr Med Mycol. 2022 Sep;8(3):1-8. doi: 10.18502/cmm.8.3.11212.
9
The SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis.SAGA 和 NuA4 组件 Tra1 调控白念珠菌的耐药性和发病机制。
Genetics. 2021 Oct 2;219(2). doi: 10.1093/genetics/iyab131.
10
Rezafungin-Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins.瑞扎芬净的作用机制、敏感性及耐药性：与其他棘白菌素类药物的异同
J Fungi (Basel). 2020 Nov 1;6(4):262. doi: 10.3390/jof6040262.
本文引用的文献
1
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.白色念珠菌棘白菌素最低抑菌浓度（MIC）与fks1突变体葡聚糖合酶动力学抑制的相关性：对解释性断点的影响
Antimicrob Agents Chemother. 2009 Jan;53(1):112-22. doi: 10.1128/AAC.01162-08. Epub 2008 Oct 27.
2
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.对卡泊芬净耐药的热带念珠菌菌株在血液系统恶性肿瘤高危患者中引起突破性真菌血症。
Antimicrob Agents Chemother. 2008 Nov;52(11):4181-3. doi: 10.1128/AAC.00802-08. Epub 2008 Sep 15.
3
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.光滑念珠菌感染继发侵袭性念珠菌病长期治疗后卡泊芬净耐药性的产生。
Antimicrob Agents Chemother. 2008 Oct;52(10):3783-5. doi: 10.1128/AAC.00473-08. Epub 2008 Aug 1.
4
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.针对念珠菌属对卡泊芬净、阿尼芬净和米卡芬净的药敏试验，其最低抑菌浓度（MIC）与结果的相关性：分析及MIC解释性折点建议
J Clin Microbiol. 2008 Aug;46(8):2620-9. doi: 10.1128/JCM.00566-08. Epub 2008 Jun 25.
5
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.近平滑念珠菌、正平滑念珠菌和副平滑念珠菌中Fks1p天然存在的脯氨酸到丙氨酸的氨基酸变化导致棘白菌素敏感性降低。
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.
6
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.念珠菌血症治疗期间因FKS1突变导致光滑念珠菌敏感性降低。
Antimicrob Agents Chemother. 2008 Jun;52(6):2263-5. doi: 10.1128/AAC.01568-07. Epub 2008 Mar 31.
7
Emergence of Candida tropicalis resistant to caspofungin.热带念珠菌对卡泊芬净耐药性的出现。
J Antimicrob Chemother. 2008 Jan;61(1):219. doi: 10.1093/jac/dkm453. Epub 2007 Nov 16.
8
Resistance to echinocandin-class antifungal drugs.对棘白菌素类抗真菌药物的耐药性。
Drug Resist Updat. 2007 Jun;10(3):121-30. doi: 10.1016/j.drup.2007.04.002. Epub 2007 Jun 13.
9
Anidulafungin versus fluconazole for invasive candidiasis.阿尼芬净与氟康唑治疗侵袭性念珠菌病的比较
N Engl J Med. 2007 Jun 14;356(24):2472-82. doi: 10.1056/NEJMoa066906.
10
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.米卡芬净与脂质体两性霉素B治疗念珠菌血症和侵袭性念珠菌病：一项III期随机双盲试验
Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9.
Zotero 插件